Animal models of orthopedic implant-related infection

Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies

Volumn 9781461410317, Issue , 2013, Pages 273-304

  Calabro, Lorenzo ^a,b   Lutton, Cameron ^a   Din, Ahmed Fouad Seif El ^a,c   Richards, R Geoff ^a   Moriarty, T Fintan ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DIAGNOSIS; IMPLANTS (SURGICAL); MUSCULOSKELETAL SYSTEM; SURGERY;

ANIMAL MODEL; CYTOCOMPATIBILITY; DIAGNOSTIC STRATEGY; IMPLANT-ASSOCIATED INFECTION; ORTHOPAEDIC IMPLANTS; PERFORMANCE; REFERENCE MODELING; RESEARCH AND DEVELOPMENT; SCIENTIFIC OUTPUT; THERAPEUTIC STRATEGY;

BIOCOMPATIBILITY;

EID: 84878829724     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1031-7_12     Document Type: Chapter

References (153)

1. Edwards C, Counsell A, Boulton C, Moran CG. Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br. 2008;90(6):770-7.
2. Schlegel U, Perren SM. Surgical aspects of infection involving osteosynthesis implants: implant design and resistance to local infection. Injury. 2006;37 Suppl 2:S67-73.
3. Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. Br J Exp Pathol. 1957;38(6):573-86.
4. Krogh A. The progress of physiology. Science. 1929;70(1809):200-4.
5. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005;16 Suppl 2:S129-38.
6. Aerssens J, Boonen S, Lowet G, Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology. 1998; 139(2):663-70.
7. Auer JA, Goodship A, Arnoczky S, Pearce S, Price J, Claes L, et al. Re fining animal models in fracture research: seeking consensus in optimising both animal welfare and scienti fic validity for appropriate biomedical use. BMC Musculoskelet Disord. 2007;8:72.
8. Patel M, Rojavin Y, Jamali AA, Wasielewski SJ, Salgado CJ. Animal models for the study of osteomyelitis. Semin Plast Surg. 2009;23(2):148-54.
9. Wang X, Mabrey JD, Agrawal CM. An interspecies comparison of bone fracture properties. Biomed Mater Eng. 1998;8(1):1-9.
10. Salgado CJ, Jamali AA, Mardini S, Buchanan K, Veit B. A model for chronic osteomyelitis using Staphylococcus aureus in goats. Clin Orthop Relat Res. 2005;436:246-50.
11. Arens S, Eijer H, Schlegel U, Printzen G, Perren SM, Hansis M. Influence of the design for fixation implants on local infection: experimental study of dynamic compression plates versus point contact fixators in rabbits. J Orthop Trauma. 1999;13(7):470-6.
12. Claes L, Eckert-Hubner K, Augat P. The effect of mechanical stability on local vascularization and tissue differentiation in callus healing. J Orthop Res. 2002;20:1099-105.
13. An YH, Friedman RJ. Animal models of orthopedic implant infection. J Invest Surg. 1998;11(2):139-46.
14. An YH, Kang QK, Arciola CR. Animal models of osteomyelitis. Int J Artif Organs. 2006; 29(4):407-20.
15. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis. 1988; 10(1):103-10.
16. Garcia P, Holstein J, Histing T, Burkhardt M, Culemann U, Pizanis A, et al. A new technique for internal fixation of femoral fractures in mice: impact of stability on fracture healing. J Biomech. 2008;41:1689-96.
17. Matthys R, Perren S. Internal fixator for use in the mouse. Injury. 2009;40:S103-9.
18. Histing T, Garcia P, Matthys R, Leidinger M, Holstein J, Kristen A, et al. An internal locking plate to study intramembranous bone healing in a mouse femur fracture model. J Orthop Res. 2010;28(3):397-402.
19. Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe. 2009;6(1):5-9.
20. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2):118-30.
21. Scheman L, Janota M, Lewin P. The production of experimental osteomyelitis. JAMA. 1941;117(18):1525-9.
22. Norden CW. Experimental osteomyelitis. I. A description of the model. J Infect Dis. 1970;122(5):410-8.
23. Rissing JP, Buxton TB, Weinstein RS, Shockley RK. Model of experimental chronic osteomyelitis in rats. Infect Immun. 1985;47(3):581-6.
24. Southwood LL, Frisbie DD, Kawcak CE, Ghivizzani SC, Evans CH, McIlwraith CW. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res. 2004;22(1):66-72.
25. Volk A, Cremieux AC, Belmatoug N, Vallois JM, Pocidalo JJ, Carbon C. Evaluation of a rabbit model for osteomyelitis by high field, high resolution imaging using the chemical-shiftspeci fic-slice-selection technique. Magn Reson Imaging. 1994;12(7):1039-46.
26. Smeltzer MS, Thomas JR, Hickmon SG, Skinner RA, Nelson CL, Griffith D, et al. Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res. 1997; 15(3):414-21.
27. Andriole VT, Nagel DA, Southwick WO. A paradigm for human chronic osteomyelitis. J Bone Joint Surg Am. 1973;55(7):1511-5.
28. Petty W, Spanier S, Shuster JJ, Silverthorne C. The influence of skeletal implants on incidence of infection. Experiments in a canine model. J Bone Joint Surg Am. 1985;67(8):1236-44.
29. Cordero J, Munuera L, Folgueira MD. Influence of metal implants on infection. An experimental study in rabbits. J Bone Joint Surg Br. 1994;76(5):717-20.
30. Arens S, Schlegel U, Printzen G, Ziegler WJ, Perren SM, Hansis M. Influence of materials for fixation implants on local infection. An experimental study of steel versus titanium DCP in rabbits. J Bone Joint Surg Br. 1996;78(4):647-51.
31. Moriarty TF, Debefve L, Boure L, Campoccia D, Schlegel U, Richards RG. Influence of material and microtopography on the development of local infection in vivo: experimental investigation in rabbits. Int J Artif Organs. 2009;32(9):663-70.
32. Moriarty TF, Schlegel U, Perren S, Richards RG. Infection in fracture fixation: can we influence infection rates through implant design? J Mater Sci Mater Med. 2010;21(3):1031-5.
33. Melcher GA, Claudi B, Schlegel U, Perren SM, Printzen G, Munzinger J. Influence of type of medullary nail on the development of local infection. An experimental study of solid and slotted nails in rabbits. J Bone Joint Surg Br. 1994;76(6):955-9.
34. Melcher GA, Metzdorf A, Schlegel U, Ziegler WJ, Perren SM, Printzen G. Influence of reaming versus nonreaming in intramedullary nailing on local infection rate: experimental investigation in rabbits. J Trauma. 1995;39(6):1123-8.
35. Melcher GA, Hauke C, Metzdorf A, Perren SM, Printzen G, Schlegel U, et al. Infection after intramedullary nailing: an experimental investigation on rabbits. Injury. 1996;27 Suppl 3:SC23-6.
36. Horn J, Schlegel U, Krettek C, Ito K. Infection resistance of unreamed solid, hollow slotted and cannulated intramedullary nails: an in-vivo experimental comparison. J Orthop Res. 2005;23(4):810-5.
37. Finkemeier CG, Schmidt AH, Kyle RF, Templeman DC, Varecka TF. A prospective, randomized study of intramedullary nails inserted with and without reaming for the treatment of open and closed fractures of the tibial shaft. J Orthop Trauma. 2000;14(3):187-93.
38. Larsen LB, Madsen JE, Hoiness PR, Ovre S. Should insertion of intramedullary nails for tibial fractures be with or without reaming? A prospective, randomized study with 3.8 years? followup. J Orthop Trauma. 2004;18(3):144-9.
39. Hendricks KJ, Burd TA, Anglen JO, Simpson AW, Christensen GD, Gainor BJ. Synergy between Staphylococcus aureus and Pseudomonas aeruginosa in a rat model of complex orthopaedic wounds. J Bone Joint Surg Am. 2001;83-A(6):855-61.
40. Deysine M, Rosario E, Isenberg HD. Acute hematogenous osteomyelitis: an experimental model. Surgery. 1976;79(1):97-9.
41. Emslie KR, Nade S. Pathogenesis and treatment of acute hematogenous osteomyelitis: evaluation of current views with reference to an animal model. Rev Infect Dis. 1986;8(6):841-9.
42. Poultsides LA, Papatheodorou LK, Karachalios TS, Khaldi L, Maniatis A, Petinaki E, et al. Novel model for studying hematogenous infection in an experimental setting of implantrelated infection by a community-acquired methicillin-resistant S. aureus strain. J Orthop Res. 2008;26(10):1355-62.
43. Hienz SA, Sakamoto H, Flock JI, Morner AC, Reinholt FP, Heimdahl A, et al. Development and characterization of a new model of hematogenous osteomyelitis in the rat. J Infect Dis. 1995;171(5):1230-6.
44. Whalen JL, Fitzgerald Jr RH, Morrissy RT. A histological study of acute hematogenous osteomyelitis following physeal injuries in rabbits. J Bone Joint Surg Am. 1988;70(9):1383-92.
45. Chadha HS, Fitzgerald Jr RH, Wiater P, Sud S, Nasser S, Wooley PH. Experimental acute hematogenous osteomyelitis in mice. I. Histopathological and immunological findings. J Orthop Res. 1999;17(3):376-81.
46. Patzakis MJ, Wilkins J. Factors influencing infection rate in open fracture wounds. Clin Orthop Relat Res. 1989;243:36-40.
47. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351 (16):1645-54.
48. Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracturefi xation devices. Injury. 2006;37 Suppl 2:S59-66.
49. Bowen TR, Widmaier JC. Host classi fication predicts infection after open fracture. Clin Orthop Relat Res. 2005;433:205-11.
50. Dumont C, Kauer F, Bohr S, Schmidtmann U, Knopp W, Engelhardt T, et al. Long-term effects of saw osteotomy versus random fracturing on bone healing and remodeling in a sheep tibia model. J Orthop Res. 2009;27(5):680-6.
51. Ashhurst DE, Hogg J, Perren SM. A method for making reproducible experimental fractures of the rabbit tibia. Injury. 1982;14(3):236-42.
52. Jackson RW, Reed CA, Israel JA, Abou-Keer FK, Garside H. Production of a standard experimental fracture. Can J Surg. 1970;13(4):415-20.
53. Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2(1):97-101.
54. Marturano JE, Cleveland BC, Byrne MA, O?Connell SL, Wixted JJ, Billiar KL. An improved murine femur fracture device for bone healing studies. J Biomech. 2008;41(6):1222-8.
55. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twentyfi ve open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976;58(4):453-8.
56. Landry P, Marino A, Sadasivan K, Albright J. Effect of soft-tissue trauma on the early periosteal response of bone to injury. J Trauma. 2000;48(3):479.
57. Li BC, Zhang JJ, Xu C, Zhang LC, Kang JY, Zhao H. Treatment of rabbit femoral defect by firearm with BMP-4 gene combined with TGF-beta1. J Trauma. 2009;66(2):450-6.
58. Utvag S, Grundnes O, Rindal D, Reikeras O. Influence of extensive muscle injury on fracture healing in rat tibia. J Orthop Trauma. 2003;17(6):430-5.
59. Claes L, Maurer-Klein N, Henke T, Gerngross H, Melnyk M, Augat P. Moderate soft tissue trauma delays new bone formation only in the early phase of fracture healing. J Orthop Res. 2006;24(6):1178-85.
60. Melnyk M, Henke T, Claes L, Augat P. Revascularisation during fracture healing with soft tissue injury. Arch Orthop Trauma Surg. 2008;128:1159-65.
61. Kälicke T, Schlegel U, Printzen G, Schneider E, Muhr G, Arens S. Influence of a standardized closed soft tissue trauma on resistance to local infection. An experimental study in rats. J Orthop Res. 2003;21(2):373-8.
62. Matsumoto T, Hardaway III RM, Dobek AS, Noyes HE. Antibiotic topical spray applied in a simulated combat wound. Arch Surg. 1967;95(2):288-94.
63. Passl R, Muller C, Zielinski CC, Eibl MM. A model of experimental post-traumatic osteomyelitis in guinea pigs. J Trauma. 1984;24(4):323-6.
64. Rittman WW, Perren S. Cortical bone healing after internal fixation and fracture. New York: Springer; 1974.
65. Worlock P, Slack R, Harvey L, Mawhinney R. An experimental model of post-traumatic osteomyelitis in rabbits. Br J Exp Pathol. 1988;69(2):235-44.
66. Worlock P, Slack R, Harvey L, Mawhinney R. The prevention of infection in open fractures: an experimental study of the effect of fracture stability. Injury. 1994;25(1):31-8.
67. Hamel A, Caillon J, Jacqueline C, Rogez JM, Potel G. Internal device decreases antibiotic's efficacy on experimental osteomyelitis. J Child Orthop. 2008;2(3):239-43.
68. Curtis MJ, Brown PR, Dick JD, Jinnah RH. Contaminated fractures of the tibia: a comparison of treatment modalities in an animal model. J Orthop Res. 1995;13(2):286-95.
69. Hill PF, Clasper JC, Parker SJ, Watkins PE. Early intramedullary nailing in an animal model of a heavily contaminated fracture of the tibia. J Orthop Res. 2002;20(4):648-53.
70. Lindsey BA, Clovis NB, Smith ES, Salihu S, Hubbard DF. An animal model for open femur fracture and osteomyelitis: part I. J Orthop Res. 2010;28(1):38-42.
71. Chen X, Tsukayama DT, Kidder LS, Bourgeault CA, Schmidt AH, Lew WD. Characterization of a chronic infection in an internally-stabilized segmental defect in the rat femur. J Orthop Res. 2005;23(4):816-23.
72. Chen X, Schmidt AH, Mahjouri S, Polly Jr DW, Lew WD. Union of a chronically infected internally stabilized segmental defect in the rat femur after debridement and application of rhBMP-2 and systemic antibiotic. J Orthop Trauma. 2007;21(10):693-700.
73. Chen X, Kidder LS, Lew WD. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res. 2002;20(1):142-50.
74. Stewart RL, Cox JT, Volgas D, Stannard J, Duffy L, Waites KB, et al. The use of a biodegradable, load-bearing scaffold as a carrier for antibiotics in an infected open fracture model. J Orthop Trauma. 2010;24(9):587-91.
75. Holstein J, Garcia P, Histing T, Kristen A, Scheuer C, Menger M, et al. Advances in the establishment of de fined mouse models for the study of fracture healing and bone regeneration. J Orthop Trauma. 2009;23:S31.
76. Frommelt L. Principles of systemic antimicrobial therapy in foreign material associated infection in bone tissue, with special focus on periprosthetic infection. Injury. 2006;37 Suppl 2:S87-94.
77. Norden CW. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin. J Infect Dis. 1975;132(5):493-9.
78. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br. 1997;79(4):590-5.
79. Rodeheaver GT, Rukstalis D, Bono M, Bellamy W. A new model of bone infection used to evaluate the efficacy of antibiotic-impregnated polymethylmethacrylate cement. Clin Orthop Relat Res. 1983;178:303-11.
80. Evans RP, Nelson CL. Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop Relat Res. 1993;295:37-42.
81. Riegels-Nielsen P, Espersen F, Holmich LR, Frimodt-Moller N. Collagen with gentamicin for prophylaxis of postoperative infection. Staphylococcus aureus osteomyelitis studied in rabbits. Acta Orthop Scand. 1995;66(1):69-72.
82. Beardmore AA, Brooks DE, Wenke JC, Thomas DB. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Am. 2005;87(1):107-12.
83. Aimin C, Chunlin H, Juliang B, Tinyin Z, Zhichao D. Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis. Clin Orthop Relat Res. 1999;366:239-47.
84. Huneault LM, Lussier B, Dubreuil P, Chouinard L, Desevaux C. Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. J Orthop Res. 2004;22(6):1351-7.
85. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37 Suppl 2:S95-104.
86. Ueng SW, Yuan LJ, Lee N, Lin SS, Chan EC, Weng JH. In vivo study of biodegradable alginate antibiotic beads in rabbits. J Orthop Res. 2004;22(3):592-9.
87. Ambrose CG, Clyburn TA, Louden K, Joseph J, Wright J, Gulati P, et al. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model. Clin Orthop Relat Res. 2004;421:293-9.
88. Li D, Gromov K, Soballe K, Puzas JE, O?Keefe RJ, Awad H, et al. Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res. 2008;26(1):96-105.
89. Antoci Jr V, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res. 2007;461:88-95.
90. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003; 32(5):521-31.
91. Strobel C, Schmidmaier G, Wildemann B. Changing the release kinetics of gentamicin from poly( d , l -lactide) implant coatings using only one polymer. Int J Artif Organs. 2011; 34(3):304-16.
92. Schmidmaier G, Lucke M, Wildemann B, Haas N, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury. 2006;37(2):S105-12.
93. Fuchs T, Stange R, Schmidmaier G, Raschke MJ. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg. 2011;131(10):1419-25.
94. Darouiche RO, Farmer J, Chaput C, Mansouri M, Saleh G, Landon GC. Anti-infective efficacy of antiseptic-coated intramedullary nails. J Bone Joint Surg Am. 1998;80(9):1336-40.
95. Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, et al. Local application of zoledronic acid incorporated in a poly( d , l -lactide)-coated implant accelerates fracture healing in rats. Acta Orthop. 2008;79(5):717-25.
96. Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone. 2009;45(3):505-11.
97. Moskowitz JS, Blaisse MR, Samuel RE, Hsu HP, Harris MB, Martin SD, et al. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials. 2010;31(23):6019-30.
98. Antoci Jr V, Adams CS, Parvizi J, Davidson HM, Composto RJ, Freeman TA, et al. The inhibition of Staphylococcus epidermidis bio film formation by vancomycin-modi fied titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials. 2008;29(35):4684-90.
99. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole-Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials. 2004;25(20):5003-12.
100. Lonn-Stensrud J, Landin MA, Benneche T, Petersen FC, Scheie AA. Furanones, potential agents for preventing Staphylococcus epidermidis bio film infections? J Antimicrob Chemother. 2009;63(2):309-16.
101. Cornell CN, Tyndall D, Waller S, Lane JM, Brause BD. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute. J Orthop Res. 1993;11(5):619-26.
102. Giavaresi G, Borsari V, Fini M, Giardino R, Sambri V, Gaibani P, et al. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: an experimental study in the rabbit. J Orthop Res. 2008;26(6):785-92.
103. Shirtliff ME, Calhoun JH, Mader JT. Experimental osteomyelitis treatment with antibioticimpregnated hydroxyapatite. Clin Orthop Relat Res. 2002;401:239-47.
104. Fitzgerald Jr RH. Experimental osteomyelitis: description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis. J Bone Joint Surg Am. 1983;65(3):371-80.
105. Garvin KL, Miyano JA, Robinson D, Giger D, Novak J, Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J Bone Joint Surg Am. 1994;76(10):1500-6.
106. Orhan Z, Cevher E, Mulazimoglu L, Gurcan D, Alper M, Araman A, et al. The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model. J Bone Joint Surg Br. 2006;88(2):270-5.
107. Del Pozo JL, Rouse MS, Euba G, Kang CI, Mandrekar JN, Steckelberg JM, et al. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother. 2009;53(10):4064-8.
108. Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthop Relat Res. 1996;332:184-9.
109. Monzon M, Garcia-Alvarez F, Lacleriga A, Amorena B. Evaluation of four experimental osteomyelitis infection models by using precolonized implants and bacterial suspensions. Acta Orthop Scand. 2002;73(1):11-9.
110. Goodhart GL. Mycobacterium fortuitum osteomyelitis following trauma. J Orthop Trauma. 1993;7(2):142-5.
111. Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, et al. Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med. 2009;35(11):1964-9.
112. Glueck DA, Charoglu CP, Lawton JN. Factors associated with infection following open distal radius fractures. Hand (N Y). 2009;4(3):330-4.
113. Mader JT, Cripps MW, Calhoun JH. Adult posttraumatic osteomyelitis of the tibia. Clin Orthop Relat Res. 1999;360:14-21.
114. Costerton JW, Post JC, Ehrlich GD, Hu FZ, Kreft R, Nistico L, et al. New methods for the detection of orthopedic and other bio film infections. FEMS Immunol Med Microbiol. 2011;61(2):133-40.
115. Cremieux AC, Dumitrescu O, Lina G, Vallee C, Cote JF, Muffat-Joly M, et al. Pantonvalentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009;4(9):e7204.
116. Daurel C, Prunier AL, Chau F, Garry L, Leclercq R, Fantin B. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus . FEMS Immunol Med Microbiol. 2007;51(2):344-9.
117. Elasri MO, Thomas JR, Skinner RA, Blevins JS, Beenken KE, Nelson CL, et al. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone. 2002; 30(1):275-80.
118. Luong TT, Lei MG, Lee CY. Staphylococcus aureus Rbf activates bio film formation in vitro and promotes virulence in a murine foreign body infection model. Infect Immun. 2009; 77(1):335-40.
119. Patti JM, Bremell T, Krajewska-Pietrasik D, Abdelnour A, Tarkowski A, Ryden C, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun. 1994;62(1):152-61.
120. Weiss EC, Spencer HJ, Daily SJ, Weiss BD, Smeltzer MS. Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of bio film formation. Antimicrob Agents Chemother. 2009;53(6):2475-82.
121. Ferguson KP, Lambe Jr DW, Keplinger JL, Kalbfleisch JH. Comparison of the pathogenicity of three species of coagulase-negative Staphylococcus in a mouse model with and without a foreign body. Can J Microbiol. 1991;37(9):722-4.
122. Fluckiger U, Ulrich M, Steinhuber A, Doring G, Mack D, Landmann R, et al. Bio film formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun. 2005;73(3):1811-9.
123. Francois P, Tu Quoc PH, Bisognano C, Kelley WL, Lew DP, Schrenzel J, et al. Lack of bio film contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis . FEMS Immunol Med Microbiol. 2003;35(2):135-40.
124. Lambe Jr DW, Ferguson KP, Keplinger JL, Gemmell CG, Kalbfleisch JH. Pathogenicity of Staphylococcus lugdunensis , Staphylococcus schleiferi , and three other coagulase-negative staphylococci in a mouse model and possible virulence factors. Can J Microbiol. 1990;36(7):455-63.
125. Lambe Jr DW, Ferguson KP, Mayberry-Carson KJ, Tober-Meyer B, Costerton JW. Foreignbody-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthop Relat Res. 1991;266:285-94.
126. Mayberry-Carson KJ, Tober-Meyer B, Gill LR, Lambe Jr DW, Hossler FE. Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron . Microbios. 1990;64(258):49-66.
127. Campoccia D, Montanaro L, Moriarty TF, Richards RG, Ravaioli S, Arciola CR. The selection of appropriate bacterial strains in preclinical evaluation of infection-resistant biomaterials. Int J Artif Organs. 2008;31(9):841-7.
128. Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, et al. Global gene expression in Staphylococcus aureus bio films. J Bacteriol. 2004;186(14):4665-84.
129. Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, et al. Transcriptional pro filing of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology. 2006;152(Pt 10):3075-90.
130. Herbert S, Ziebandt AK, Ohlsen K, Schafer T, Hecker M, Albrecht D, et al. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun. 2010;78(6):2877-89.
131. Sivadon V, Rottman M, Chaverot S, Quincampoix JC, de Avettand V, Mazancourt P, et al. Use of genotypic identi fication by sodA sequencing in a prospective study to examine the distribution of coagulase-negative Staphylococcus species among strains recovered during septic orthopedic surgery and evaluate their signi ficance. J Clin Microbiol. 2005;43(6):2952-4.
132. Mayberry-Carson KJ, Tober-Meyer B, Lambe Jr DW, Costerton JW. Osteomyelitis experimentally induced with Bacteroides thetaiotaomicron and Staphylococcus epidermidis . Influence of a foreign-body implant. Clin Orthop Relat Res. 1992;280:289-99.
133. Marberry KM, Kazmier P, Simpson WA, Christensen GD, Phaup JG, Hendricks KJ, et al. Surfactant wound irrigation for the treatment of staphylococcal clinical isolates. Clin Orthop Relat Res. 2002;403:73-9.
134. Hidaka S. An experimental study on pyogenic osteomyelitis with special reference to polymicrobial infections. Nippon Seikeigeka Gakkai Zasshi. 1985;59(4):429-41.
135. Johansson A, Svensson O, Blomgren G, Eliasson G, Nord CE. Anaerobic osteomyelitis. A new experimental rabbit model. Clin Orthop Relat Res. 1991;265:297-301.
136. Blomgren G, Lundquist H, Nord CE, Lindgren U. Late anaerobic haematogenous infection of experimental total joint replacement. A study in the rabbit using Propionibacterium acnes . J Bone Joint Surg Br. 1981;63B(4):614-8.
137. Blomgren G. Hematogenous infection of total joint replacement. An experimental study in the rabbit. Acta Orthop Scand Suppl. 1981;187:1-64.
138. Costerton JW. Bio film theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7-11.
139. Stoodley P, Nistico L, Johnson S, Lasko LA, Baratz M, Gahlot V, et al. Direct demonstration of viable Staphylococcus aureus bio films in an infected total joint arthroplasty. A case report. J Bone Joint Surg Am. 2008;90(8):1751-8.
140. Gristina AG, Costerton JW. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthop Clin North Am. 1984;15(3):517-35.
141. Smith K, Perez A, Ramage G, Lappin D, Gemmell CG, Lang S. Bio film formation by Scottish clinical isolates of Staphylococcus aureus . J Med Microbiol. 2008;57(Pt 8):1018-23.
142. Fitzpatrick F, Humphreys H, O?Gara JP. Evidence for icaADBC-independent bio film development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol. 2005;43(4):1973-6.
143. O?Neill E, Pozzi C, Houston P, Humphreys H, Robinson DA, Loughman A, et al. A novel Staphylococcus aureus bio film phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol. 2008;190(11):3835-50.
144. Campoccia D, Speziale P, Ravaioli S, Cangini I, Rindi S, Pirini V, et al. The presence of both bone sialoprotein-binding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections. Biomaterials. 2009;30(34):6621-8.
145. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585-617.
146. Patti JM, Hook M. Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol. 1994;6(5):752-8.
147. Vazquez V, Liang X, Horndahl JK, Ganesh VK, Smeds E, Foster TJ, et al. Fibrinogen is a ligand for the S. aureus MSCRAMM Bbp (bone sialoprotein-binding protein). J Biol Chem. 2011;286(34):29797-805.
148. Johansson A, Flock JI, Svensson O. Collagen and fibronectin binding in experimental staphylococcal osteomyelitis. Clin Orthop Relat Res. 2001;382:241-6.
149. Darouiche RO, Landon GC, Patti JM, Nguyen LL, Fernau RC, McDevitt D, et al. Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results modeldependent? J Med Microbiol. 1997;46(1):75-9.
150. Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus . Pediatr Infect Dis J. 2007;26(11):1042-8.
151. Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007;13(4):594-600.
152. Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-de ficient and alpha-toxinde ficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun. 1987;55(12):3103-10.
153. An YH, Bradley J, Powers DL, Friedman RJ. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J Bone Joint Surg Br. 1997;79(5):816-9.